메뉴 건너뛰기




Volumn 31, Issue 5, 2011, Pages 659-661

Effects of add-on cilostazol on cognition in patients with schizophrenia: An open-label pilot trial

Author keywords

[No Author keywords available]

Indexed keywords

BIPERIDEN; CILOSTAZOL; QUETIAPINE; RISPERIDONE;

EID: 80052458222     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31822c94fd     Document Type: Letter
Times cited : (10)

References (7)
  • 1
    • 34247475722 scopus 로고    scopus 로고
    • Stimulating the development of drug treatments to improve cognition in schizophrenia
    • DOI 10.1146/annurev.clinpsy.3.022806.091529
    • Green MF. Stimulating the development of drug treatments to improve cognition in schizophrenia. Annu Rev Psychol. 2007;3:159-180. (Pubitemid 46651125)
    • (2007) Annual Review of Clinical Psychology , vol.3 , pp. 159-180
    • Green, M.F.1
  • 2
    • 33645922748 scopus 로고    scopus 로고
    • Determinants of real-world functional performance in schizophrenia subjects: Correlations with cognition, functional capacity, and symptoms
    • DOI 10.1176/appi.ajp.163.3.418
    • Bowie CR, Reinchenberg A, Patterson TL, et al. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry. 2006;163:418-425. (Pubitemid 44469383)
    • (2006) American Journal of Psychiatry , vol.163 , Issue.3 , pp. 418-425
    • Bowie, C.R.1    Reichenberg, A.2    Patterson, T.L.3    Heaton, R.K.4    Harvey, P.D.5
  • 3
    • 77956587570 scopus 로고    scopus 로고
    • Prediction of real-world functional disability in chronic mental disorders: A comparison of schizophrenia and bipolar disorder
    • Bowie CR, Depp C, McGrath JA, et al. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am J Psychiatry. 2010;167:1116-1124.
    • (2010) Am J Psychiatry , vol.167 , pp. 1116-1124
    • Bowie, C.R.1    Depp, C.2    McGrath, J.A.3
  • 4
    • 33747329318 scopus 로고    scopus 로고
    • Pharmacological approaches to the management of cognitive dysfunction in schizophrenia
    • Harvey PD, McClure MM. Pharmacological approaches to the management of cognitive dysfunction in schizophrenia. Drugs. 2006;66:1465-1473.
    • (2006) Drugs , vol.66 , pp. 1465-1473
    • Harvey, P.D.1    McClure, M.M.2
  • 5
    • 36749058569 scopus 로고    scopus 로고
    • Cilostazol: A new drug in the treatment intermittent claudication
    • DOI 10.2174/157489007782418991
    • Kumar M, Bhattacharya V. Cilostazol: a new drug in the treatment intermittent claudication. Recent Pat Cardiovasc Drug Discov. 2007;2:181-185. (Pubitemid 350200286)
    • (2007) Recent Patents on Cardiovascular Drug Discovery , vol.2 , Issue.3 , pp. 181-185
    • Kumar, M.1    Bhattacharya, V.2
  • 6
    • 77956636514 scopus 로고    scopus 로고
    • Effects of cilostazol on dizocilpine-induced hyperlocomotion and prepulse inhibition deficits in mice
    • Hashimoto K, Fujita Y, Horio M, et al. Effects of cilostazol on dizocilpine-induced hyperlocomotion and prepulse inhibition deficits in mice. Clin Psychopharmacol Neurosci. 2010;8:74-78.
    • (2010) Clin Psychopharmacol Neurosci , vol.8 , pp. 74-78
    • Hashimoto, K.1    Fujita, Y.2    Horio, M.3
  • 7
    • 77952020418 scopus 로고    scopus 로고
    • Effects of cilostazol on cognitive deficits in mice after repeated administration of phencyclidine
    • Hashimoto K, Fujita Y, Ishima T, et al. Effects of cilostazol on cognitive deficits in mice after repeated administration of phencyclidine. Clin Psychopharmacol Neurosci. 2010;8:26-29.
    • (2010) Clin Psychopharmacol Neurosci , vol.8 , pp. 26-29
    • Hashimoto, K.1    Fujita, Y.2    Ishima, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.